specialti pharma top-read note april
steadi interest agn/akrx special situat myl/pcrx focu high
includ link top-read note publish april proxi see
greatest investor interest seen interest two name effect becom special
situat share link outcom strateg review case deal break litig
case remain subject debat frustrat driven stagnant stock
despit solid unclear strateg path review on-going frustrat push higher
news briefli consid make bid shpg link follow earn call
monday laid five bucket strateg consider link interest akrk ramp well
fuel fre termin merger agreement alleg materi breach fda data integr
subsequ file litig enforc link also saw pick-up incom calls/
email analyst day debat remain consist high stock volatil
specialti pharma notes/report publish april top rank order
read activ link remaind pp
agn shpg head fake non-ev reaction strong still favor asset sale apr
fre termin deal vigor defend stock link litig apr
sever import updat next month matter focu apr
thought post lunch near-term challeng remain option build apr
rais target attract near-term trade path question analyst day apr
analyst day updat lack surpris beyond updat catalyst still set summer apr
stand bull/bear debat question upcom meet apr
review complaint add color fre claim still see path close apr
industri new york doctor day migrain panel takeaway cgrp data point cgrp
debat read teva apr
industri specialti pharma focus week back agn/jazz thought
agn earli talk shpg skeptic high deal unlik view/proforma analysi apr
sever thing learn dinner manag drill main debat apr
industri specialti pharma focus week view gener read
industri new york doctor day aesthet panel takeaway inject debat aesthet toxin/
zilretta survey provid favor initi feedback ahead manag meet apr
price prior trade day market close estimate unless otherwis note
valu usd unless otherwis note
capit market appreci consider institut investor all-america research survey
specialti pharma top-read note april
implic key near-term catalyst apr
industri specialti pharma focus week biocon/hikma gx cross-
industri fda gener drug forum takeaway focu gener sector trend
weak surpris earli cross-read view apr
industri gener top sector takeaways/cross-read lunch
hikma ceo apr
industri specialti pharma cgrp primer market model address import
question ahead cgrp entri teva posit apr
cgrp entri read agn/teva apr
learn manag trip buyer
agn achiev ii data add case ubrogep safeti question remain apr
import question manag post nerv block approv apr
industri specialti pharma top-read note march apr
kmph attent shift firmli mid-year data near-term catalyst pathway rich
industri specialti pharma short interest focu high take closer look
si apr
industri specialti pharma focus week analyst day
call/dinn lunch teva investor meet apr
industri specialti pharma short interest trade call ahead
industri specialti pharma focus week pcrx/myl feedback
analyst day ny ny day nv gx kick-off apr
specialti pharma top-read note april
file litig enforc outcom expect step offici apr
industri gener pharma addit sandoz/gener color nv call broad
agn call action clear need execut view path ahead apr
 snda nerv block offici approv big posit surpris cc
mon et apr
 consid sale women busi per bloomberg import step
industri see first gener vasostrict file inevit still
 pdufa extens announc elagolix thought rel esmya apr
 new q-code medicar reimburs posit surpris import
read-through j-code apr
acquisit somerset small deal encourag data
 easl phase centaur data set present easl today chang
agn agn street full year rais strateg intent still focu
 doubl digit growth continu per symphoni updat set-up
introduc five strateg option bucket risk noth remain
 dsuvia factor studi complet re-submiss reiter
host manag meet week apr
 dzuveo receiv posit chmp opinion europ anoth encourag
specialti pharma top-read note april
analyst respons prepar research report receiv compens base upon variou factor includ
total revenu member compani capit market affili portion gener
invest bank activ member compani capit market affili
pleas note current conflict disclosur may differ public date set forth
report access current conflict disclosur client refer http //www rbccm com/gldisclosure/publicweb/
send request cm research publish bay street royal bank plaza
capit market llc make market secur allergan public limit compani
capit market provid allergan public limit compani non-invest bank securities-rel servic
past month
capit market llc make market secur akorn inc
capit market llc make market secur
capit market llc make market secur inc
explan capit market equiti rate system
analyst sector univers compani analyst provid research coverag accordingli rate assign
particular stock repres sole analyst view stock perform next month rel
top pick tp repres analyst best idea sector expect provid signific absolut total return month
favor risk-reward ratio
outperform expect materi outperform sector averag month
sector perform sp return expect line sector averag month
under-perform return expect materi sector averag month
restrict polici preclud certain type commun includ invest recommend
act advisor certain merger strateg transact certain circumst
rate nr rate price target estim remov due applic legal regulatori polici constraint
may includ capit market act advisori capac involv compani
specul risk rate reflect secur lower level financi oper predict illiquid share trade volum
high balanc sheet leverag limit oper histori result higher expect financi and/or stock price volatil
specialti pharma top-read note april
distribut rate
purpos rate distribut regulatori rule requir member firm assign rate one three rate categori
 buy hold/neutr sell regardless firm rate categori although capit market rate top pick/
outperform sector perform under-perform close correspond buy hold/neutr sell respect mean
rate determin rel basi
distribut rate
specialti pharma top-read note april
specialti pharma top-read note april
refer recommend list recommend histori chart may includ one recommend list model
portfolio maintain wealth manag one affili wealth manag recommend list includ
guid portfolio prime incom rl guid portfolio dividend growth rl guid portfolio adr rl
guid portfolio cap growth rl former list call guid portfolio larg cap rl guid portfolio
mid-cap rl guid portfolio global equiti rl capit market recommend list includ
strategi focu list fundament equiti weight portfolio abbrevi rl mean date secur
place recommend list abbrevi rl mean date secur remov recommend list
equiti valuat risk
valuat method use determin risk may imped achiev price target cover compani pleas
see recent company-specif research report http //www rbcinsightresearch com send request capit
price target base scenario analysi reflect follow deal close full per-shar take-out
price probabl deal close discount deal price per share probabl deal break
materi linger concern leav peer group ev/ebitda multipl impli per share
probabl deal break linger materi concern leav sector low/trough ebitda multipl
per share probabl given magnitud risk uncertainti involv believ price target impli return
support sector perform rate
risk rate price target
sluggish pace new product approv lower gross margin new product sever price eros older product
inabl suppli product due one sever reason raw materi shortag shutdown compani owned/leas
manufactur facil delay shipment product manufactur outsourc supplier takeout
would impact base-cas price target
specialti pharma top-read note april
price target base equal price-to-earnings ev/ebitda pro-forma forecast reflect
single-digit ep growth forecast price target impli return support outperform rate
risk rate price target
risk price target rate includ limit actual cost synergi recent transact fall
expect competit key product prove intens model
price target base equal price-to-earnings ev/ebitda use target multipl
gener line specialti peer believ reflect current sector challeng heighten leverag rel
histor level impli return price target support sector perform rate
risk rate price target
risk rate price target includ limit earlier-than-expect approv key product advair
extend delay accret drive favor accret addit pipelin surpris
price target base equal discount cash flow dcf analysi discount price-to-earnings dcf yield per share
reflect explicit forecast wacc termin growth rate beyond price-to-earnings get us per
share ep impli return price target support outperform rate
risk rate price target
potenti downsid risk price target rate aris price risk key concern may imped
adopt greater util regulatory/bundl risk bundl payment orthoped procedur
competit risk data risk ph iv read-out pipelin product develop
capit market polici manag conflict interest relat invest research avail us request
access current polici client refer
send request capit market research publish bay street royal bank plaza floor south
tower toronto ontario reserv right amend supplement polici time
dissemin research short-term trade idea
capit market endeavor make reason effort provid research simultan elig client
regard local time zone oversea jurisdict capit market equiti research post proprietari websit
ensur elig client receiv coverag initi chang rate target opinion time manner addit
distribut may done sale personnel via email fax electron mean regular mail client may also
receiv research via third parti vendor capit market also provid elig client access sparc firm
proprietari insight websit via email via third-parti vendor sparc contain market color commentari regard
subject compani firm current provid equiti research coverag research analyst may time time
includ short-term trade idea research report sparc short-term trade idea offer short-term view
secur may trade base market trade event result trade opportun may avail
short-term trade idea may differ price target recommend publish research report reflect
specialti pharma top-read note april
research analyst view long-term one year prospect subject compani result differ time horizon
methodolog and/or factor thu possibl subject compani common equiti consid long-term
sector perform even under-perform might present short-term buy opportun result temporari sell pressur
market convers subject compani common equiti rate long-term outperform could consid suscept
short-term downward price correct short-term trade idea rate part rate system
firm gener intend undertak oblig maintain updat short-term trade idea short-term trade
idea may suitabl investor tailor individu investor circumst object
investor make independ decis regard secur strategi discuss herein pleas contact
invest advisor institut salesperson inform regard capit market research
list recommend compani dissemin prior period pleas click
month histori sparc view http //www rbcinsightresearch com
view express report accur reflect person view respons analyst
subject secur issuer part compens respons analyst name herein directli
indirectli relat specif recommend view express respons analyst report
global industri classif standard gic develop exclus properti servic mark inc standard poor financi servic
llc licens use neither parti involv make compil gic gic classif make express impli
warranti represent respect standard classif result obtain use thereof parti herebi expressli disclaim warranti
origin accuraci complet merchant fit particular purpos respect standard classif without limit forego
event shall affili third parti involv make compil gic gic classif liabil direct indirect special
punit consequenti damag includ lost profit even notifi possibl damag
refer herein libor libo rate libor abbrevi mean london interbank offer rate administ benchmark administr
person take administr rate
capit market busi name use certain branch subsidiari royal bank canada includ dominion secur inc
capit market llc europ limit royal bank canada hong kong branch royal bank canada sydney branch inform contain
report compil capit market sourc believ reliabl represent warranti express impli made royal
canada capit market affili person accuraci complet correct opinion estim contain
report constitut capit market judgement date report subject chang without notic provid good faith without
legal respons noth report constitut legal account tax advic individu tailor invest advic materi prepar gener
circul client prepar without regard individu financi circumst object person receiv invest
servic contain report may suitabl recommend consult independ invest advisor doubt
suitabl invest servic report offer sell solicit offer buy secur past perform guid
futur perform futur return guarante loss origin capit may occur capit market research analyst compens base
part overal profit capit market includ profit attribut invest bank revenu everi provinc canada state
 countri throughout world law regul type secur invest product may offer
resid well process result secur discuss report may elig sale jurisdict
capit market may restrict publish research report time time due regulatori restrict and/ intern complianc polici
case latest publish research report avail client may reflect recent materi chang applic industri and/or applic subject
compani capit market research report current date set forth research report report circumst
constru solicit act secur broker dealer jurisdict person compani legal permit carri
busi secur broker dealer jurisdict full extent permit law neither capit market affili
person accept liabil whatsoev direct consequenti loss aris use report inform contain herein matter
contain document may reproduc copi mean without prior consent capit market
addit inform avail request
public approv capit market llc member finra nyse sipc regist broker-deal accept
respons report dissemin unit state recipi report regist broker-deal bank act
broker dealer capac wish inform regard effect transact secur discuss report
contact place order capit market llc
public approv dominion secur inc member iiroc canadian recipi report design institut
ontario accredit investor british columbia alberta sophist purchas quebec similar permit purchas provinc
specialti pharma top-read note april
wish inform regard effect transact secur discuss report contact place order
dominion secur inc without way limit forego accept respons report dissemin canada
public approv europ limit el author prudenti regul author regul
conduct author fca prudenti regul author connect distribut unit kingdom materi gener
distribut unit kingdom retail client defin rule fca rbcel accept respons report dissemin
unit kingdom
materi distribut germani europ limit frankfurt branch regul bundesanstalt fr finanzdienstleistungsaufsicht bafin
receiv advic australia
materi distribut australia royal bank canada sydney branch abn afsl materi prepar
gener circul take account object financi situat need recipi accordingli recipi act
materi consid appropri materi regard object financi situat need materi relat acquisit
possibl acquisit particular financi product recipi australia obtain relev disclosur document prepar respect product
